
10 September 2021
MiLOC GROUP LIMITED
("MiLOC" or "the Company")
NOTICE OF AGM AND ISSUED SHARES
MiLOC Group Limited (AQSE: ML.P), the AQSE Growth Market quoted pharmaceutical and healthcare group, is pleased to announce that the Annual General Meeting (the "AGM") of the Company will be held at Room 1602, 16/F Kodak House II, 39 Healthy Street East, North Point,
Copies of the Company's Notice of the AGM have been distributed to shareholders. Electronic copies of the Notice of AGM as well as the Company's Annual Report and Financial Statements for the year ended 31 December 2020 are available from the Company's website www.miloc.com.
The Company notes an error in the announcement dated 4 June 2021. The actual number of Ordinary Shares in issue is 85,499,442 (not 85,449,442).
The Company announces that, following the issue of Ordinary Shares referred to in the announcement on 4th June 2021, in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules (the "Disclosure and Transparency Rules"), the total number of Ordinary Shares in issue will be 85,499,442 with each share carrying the right to one vote.
MiLOC does not hold any shares in Treasury.
The above figure of 85,499,442 ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.
The Directors of the issuer accept responsibility for the contents of this announcement.
For further information, please contact:-
MiLOC ONG Ban Poh Michael - Chief Executive Officer Ronnie CHOI - Chief Financial Officer
|
Tel: +852 2110 4221
|
AQSE Growth Market Corporate Adviser PETERHOUSE CORPORATE LIMITED Guy Miller Mark Anwyl |
Tel: +44 (0) 20 7469 0930 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.